NASDAQ: AMSSAmass Brands Stock
$1.71-0.16 (-8.56%)
Updated Jul 7, 2026
AMSS Price
$1.71
Fair Value Price
N/A
Market Cap
$19.54M
52 Week Low
$1.65
52 Week High
$17.00
P/E
N/A
P/B
-3.7x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-5.4
Operating Cash Flow
N/A
Beta
2.24
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
AMSS Overview
AMASS Brands, Inc. develops and distributes a diverse array of botanical-infused items, spanning both alcoholic and non-alcoholic drinks, alongside personal wellness products. Its beverage selection features various botanical spirits, including dry gin, vodka crafted from botanicals, and unique limited-edition spirits enriched with adaptogenic ingredients. For those seeking alcohol-free options, AMASS offers beverages specifically formulated for social events or personal moments of self-care. The company's personal care line, branded Midori Maison, includes items such as candles, soaps, and hand sanitizers. A core principle across all AMASS products is their composition of solely natural, non-GMO botanical ingredients, deliberately excluding artificial preservatives and superfluous chemicals. The company is committed to providing plant-derived solutions suitable for a broad spectrum of uses, from daily routines to significant celebratory occasions. Established in 2018, AMASS Brands operates out of Los Angeles, California.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AMSS's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Wine
Industry Rating
F
AMSS
Ranked#6 of 10
Ranked#6 of 10
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $16.63 | C | |
| $131.76 | C | |
| $25.91 | C |
Be the first to know about important AMSS news, forecast changes, insider trades & much more!
AMSS News
Overview
Due Diligence Score
–
Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AMSS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AMSS's short-term liabilities ($25.57M) exceed its short-term assets ($16.42M)
Short-term Liabilities Financials
AMSS's short-term assets ($16.42M) exceed its long-term liabilities ($2.94M)
Long-term Liabilities Financials
AMSS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
There are 30 more AMSS due diligence checks available for Premium users.
Valuation
AMSS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-3.7x
Industry
2.99x
AMSS's financial health
Profit margin
Revenue
$4.1M
Net Income
-$3.0M
Profit Margin
-73.2%
Assets to liabilities
Assets
$25.6M
Liabilities
$28.5M
Debt to equity
-5.4
AMSS's short-term liabilities ($25.57M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AMSS's short-term assets ($16.42M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AMSS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AMSS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.8M
Investing
$261.3k
Financing
$1.7M
AMSS vs Wine Stocks
Amass Brands Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.